Search

Your search keyword '"Kaplan Z"' showing total 591 results

Search Constraints

Start Over You searched for: Author "Kaplan Z" Remove constraint Author: "Kaplan Z"
591 results on '"Kaplan Z"'

Search Results

6. Management of Gestational Diabetes Mellitus

11. Regional disparities in the use of intensive chemotherapy for AML in the Netherlands: Does it influence survival?

12. Regional disparities in the use of intensive chemotherapy for AML in the Netherlands:Does it influence survival?

13. Health-related quality of life (HRQoL) after different axillary treatments in women with breast cancer:a 1-year longitudinal cohort study

18. OC 65.1 Long-Term Efficacy and Safety with Oral Bruton Tyrosine Kinase Inhibitor Rilzabrutinib in Patients with Immune Thrombocytopenia

19. Health care utilization and outcomes in older adults after Traumatic Brain Injury: A CENTER-TBI study

21. Neonatal Antibodies are Detected in Cord Blood After Vaccination of Pregnant Woman with the Inactivated SARS-CoV-2 Vaccine: A Case Report.

22. Health care utilization and outcomes in older adults after Traumatic Brain Injury: a CENTER-TBI study

23. Intramural Healthcare Consumption and Costs After Traumatic Brain Injury:A Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) Study

26. S291: PHASE I/II STUDY OF RILZABRUTINIB, AN ORAL BRUTON TYROSINE KINASE INHIBITOR, IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: LONG-TERM FOLLOW-UP

27. Newborn Hearing Screening Results of Infants Born To Mothers Who Had COVID-19 Disease During Pregnancy: A Retrospective Cohort Study

28. Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia.

29. Updated Phase I/II Safety and Efficacy Results for Oral Bruton Tyrosine Kinase Inhibitor Rilzabrutinib in Patients with Relapsed/Refractory Immune Thrombocytopenia.

30. Phase i/ii study of rilzabrutinib, an oral bruton tyrosine kinase inhibitor, in patients with immune thrombocytopenia: long-term follow-up.

31. Newborn Hearing Screening Results of Infants Born To Mothers Who Had COVID-19 Disease During Pregnancy: A Retrospective Cohort Study

32. Health care utilization and outcomes in older adults after Traumatic Brain Injury:A CENTER-TBI study

33. Prediction Models for Future High-Need High-Cost Healthcare Use:a Systematic Review

35. Do fetuin-A/apha2-Heremans Schmid-glycoprotein levels have an association with recurrent pregnancy loss?

37. Newborn Hearing Screening Results of Infants Born To Mothers Who Had COVID-19 Disease During Pregnancy: A Retrospective Cohort Study

39. Reduced Trabecular Bone Score is Associated with Non-Vertebral Fractures and Nephrolithiasis in Transfusion-Dependent Thalassemia.

40. Relationship between myocardial T2*, hepatic T2* and biventricular function from cardiac MRI performed on patients with thalassaemia.

41. Inherited Thrombophilias Are Associated with an Increased Risk of COVID-19 Associated Venous Thromboembolism: A Prospective Population-Based Cohort Study.

42. Phase I/II updated safety and efficacy results of oral bruton tyrosine kinase (BTK) inhibitor rilzabrutinib in relapsed/refractory immune thrombocytopenia (ITP).

43. Phase i/ii ongoing study of rilzabrutinib, an oral bruton tyrosine kinase inhibitor, in immune thrombocytopenia: EXTENDED follow-up and long-term analyses with optimal dose.

44. 426. Phase I/II Ongoing Study of Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Immune Thrombocytopenia: Extended Follow‐up and Long‐term Analyses with Optimal Dose

45. Pladias Database of the Czech flora and vegetation. Pladias – databáze české flóry a vegetace

47. TRY plant trait database – enhanced coverage and open access

48. Phase I/II, open-label, ongoing study of PRN1008 (rilzabrutinib), an oral bruton tyrosine kinase inhibitor, in patients with heavily pretreated immune thrombocytopenia (ITP).

Catalog

Books, media, physical & digital resources